Stock Ideas
New
Stocks
Funds
Screener
Sectors
Watchlists
CLSN

CLSN - Celsion Corp Stock Price, Fair Value and News

1.41USD+0.01 (+0.71%)Market Closed

Market Summary

CLSN
USD1.41+0.01
Market Closed
0.71%

CLSN Stock Price

View Fullscreen

CLSN RSI Chart

CLSN Valuation

Market Cap

13.3M

Price/Earnings (Trailing)

-0.7

Price/Sales (Trailing)

27.83

EV/EBITDA

-0.53

Price/Free Cashflow

-0.62

CLSN Price/Sales (Trailing)

CLSN Profitability

EBT Margin

-4159.07%

Return on Equity

-221.81%

Return on Assets

-131.61%

Free Cashflow Yield

-160.09%

CLSN Fundamentals

CLSN Revenue

Revenue (TTM)

500.0K

CLSN Earnings

Earnings (TTM)

-18.9M

Earnings Growth (Yr)

11.84%

Earnings Growth (Qtr)

-0.85%

Breaking Down CLSN Revenue

Last 7 days

2.2%

Last 30 days

23.7%

Last 90 days

171.2%

Trailing 12 Months

-38.9%

How does CLSN drawdown profile look like?

CLSN Financial Health

Current Ratio

2.51

CLSN Investor Care

Shares Dilution (1Y)

3.34%

Diluted EPS (TTM)

-2.01

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
20230000
2022500.0K500.0K500.0K500.0K
2021500.0K500.0K500.0K500.0K
2020512.1K492.5K443.1K500.0K
20192.1M2.1M2.2M2.1M
2018649.7K649.7K631.3K456.5K
2017500.0K500.0K500.0K649.7K
2016500.0K500.0K500.0K500.0K
2015500.0K500.0K500.0K500.0K
2014500.0K500.0K500.0K500.0K
2013125.0K250.0K375.0K500.0K
20110002.0M

Tracking the Latest Insider Buys and Sells of Celsion Corp

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
Jul 18, 2022
le goff corinne
acquired
-
-
53,000
president and ceo
Apr 12, 2022
tardugno michael h
bought
14,129
3.5323
4,000
chairman, president and ceo
Apr 08, 2022
fritz frederick j.
bought
20,250
4.05
5,000
-
Mar 02, 2022
fritz frederick j.
bought
9,372
4.686
2,000
-
Dec 14, 2021
kardaras constantine john
acquired
-
-
10,000
chief accounting officer
Oct 07, 2021
fritz frederick j.
bought
17,600
0.88
20,000
-
May 17, 2021
braun donald p
bought
5,350
1.07
5,000
-
Feb 28, 2020
martinez alberto r jr
bought
4,500
0.9
5,000
-
Feb 25, 2020
church jeffrey wayne
acquired
54,520
1.16
47,000
cfo
Feb 25, 2020
tumminello timothy j
acquired
16,820
1.16
14,500
controller

1–10 of 22

Which funds bought or sold CLSN recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
May 16, 2024
Colony Group, LLC
new
-
46,000
46,000
-%
May 15, 2024
STATE STREET CORP
unchanged
-
13,731
23,457
-%
May 15, 2024
MORGAN STANLEY
unchanged
-
1,566
2,675
-%
May 15, 2024
BANK OF AMERICA CORP /DE/
sold off
-100
-93.00
-
-%
May 15, 2024
Federation des caisses Desjardins du Quebec
new
-
216
216
-%
May 15, 2024
Tower Research Capital LLC (TRC)
reduced
-47.47
1,501
7,121
-%
May 15, 2024
TWO SIGMA SECURITIES, LLC
sold off
-100
-9,412
-
-%
May 15, 2024
Royal Bank of Canada
reduced
-50.00
-
-
-%
May 15, 2024
CITADEL ADVISORS LLC
sold off
-100
-20,147
-
-%
May 13, 2024
RENAISSANCE TECHNOLOGIES LLC
added
14.87
111,000
174,000
-%

1–10 of 26

Are Funds Buying or Selling CLSN?

Are funds buying CLSN calls or puts?
Calls
Puts
No. of funds holding Calls - Puts
Net Call Options
No. of funds that own CLSN
No. of Funds

Unveiling Celsion Corp's Major ShareHolders

Date FiledName of FilerPercent of ClassNo. of SharesForm Type
Feb 14, 2022
cvi investments, inc.
1.3%
1,100,000
SC 13G/A
Feb 11, 2022
altium capital management lp
0%
0
SC 13G/A
Feb 01, 2021
ayrton capital llc
8.95%
5,555,555
SC 13G
Jan 29, 2021
cvi investments, inc.
-
5,555,555
SC 13G
Jan 29, 2021
altium capital management lp
8.9%
5,555,555
SC 13G
Jan 29, 2021
cvi investments, inc.
-
1,100,000
SC 13G/A
Jan 25, 2021
fivemore fund ltd
4.34%
2,750,000
SC 13D
Mar 06, 2020
cvi investments, inc.
5.6%
1,571,429
SC 13G
Mar 02, 2020
lincoln park capital fund, llc
5.49%
1,581,429
SC 13G

Recent SEC filings of Celsion Corp

View All Filings
Date Filed Form Type Document
May 15, 2024
S-3
S-3
May 14, 2024
4
Insider Trading
May 13, 2024
10-Q
Quarterly Report
May 13, 2024
8-K
Current Report
May 08, 2024
8-K
Current Report
Apr 29, 2024
ARS
ARS
Apr 26, 2024
DEF 14A
DEF 14A
Apr 11, 2024
8-K
Current Report
Apr 10, 2024
RW
RW
Mar 28, 2024
8-K
Current Report

Celsion Corp News

Latest updates
Yahoo News Australia • 06 May 2024 • 07:24 am
AOL • 7 years ago

Celsion Corp Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)
Income Statement (Quarterly)
(In Thousands)
(*) denotes actual numbers (not divided by Thousands)
Description(%) Q/Q2023Q42022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q42018Q32018Q22018Q1
Revenue-100.0%-125,000125,000125,000125,000125,000125,000125,000125,000125,000125,000125,000125,00068,050174,439144,6021,754,88599,932106,565125,000125,000
Operating Expenses-15.4%5,967,6277,051,7516,299,5666,103,2715,966,9775,615,8685,186,5765,196,4025,508,3444,918,8404,284,6004,891,9974,890,9954,872,6665,512,5265,694,7584,985,5234,875,3674,147,2208,136,353-
  S&GA Expenses-40.4%2,414,8334,048,4803,890,8862,876,9762,871,5572,629,6322,718,5102,602,9902,936,7712,108,6471,792,9041,901,1361,838,9061,807,3291,838,2872,136,6842,217,8642,531,7811,959,9033,542,8091,665,028
  R&D Expenses18.3%3,552,7943,003,2712,408,6803,226,2953,095,4202,986,2362,468,0662,593,4122,571,5732,810,2132,491,6962,990,8613,052,0493,065,3373,674,2393,558,0742,767,6592,343,5862,187,3174,593,544-
EBITDA Margin37.2%-40.75-64.91-34.63-34.45-33.65-41.80-43.15-42.87-42.83------------
Interest Expenses-100.0%-367,513127,025105,0244,211,856114,17195,520221,227120,313606,425198,739243,875243,299246,145252,144255,182253,289253,808248,270--
EBT Margin44.5%-41.59-74.93-44.31-44.31-44.31-44.31-46.66-46.66-46.66------------
Net Income63.1%-4,888,133-13,232,675-6,148,290-6,042,937-10,474,332-4,221,306-5,410,544-5,448,397-5,689,003-3,012,152-8,071,596-5,342,935-5,056,878-3,102,759-5,476,807-5,904,515-2,367,4525,480,578-4,656,386-8,230,556-
Net Income Margin45.6%-39.03-71.80-53.77-52.30-51.11-41.54-39.12-44.44-44.23------------
Free Cashflow25.8%-3,750,117-5,052,467-4,697,100-5,582,718-8,032,410-5,113,734-3,845,085-2,712,938-4,863,459------------
Balance Sheet
(In Millions)
Balance Sheet
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2024Q12023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q1
Assets-34.6%14.0022.0025.0029.0042.0044.0061.0065.0064.0074.0079.0083.0073.0038.0037.0047.0039.0038.0041.0044.0045.00
  Current Assets-33.7%12.0018.0022.0027.0036.0037.0040.0045.0044.0052.0057.0060.0056.0019.0020.0027.0019.0016.0020.0023.0025.00
    Cash Equivalents-59.8%2.006.0013.007.0010.0011.0027.0027.0028.0020.0026.0026.0038.0017.0018.0023.006.007.009.006.004.00
  Net PPE-7.8%1.001.001.001.001.001.001.001.000.000.000.000.000.000.000.000.000.000.000.000.000.00
  Goodwill-----------2.002.002.002.002.002.002.002.002.002.002.00
Liabilities-31.7%6.009.007.007.0015.0015.0019.0018.0018.0018.0020.0019.0018.0019.0019.0023.0023.0024.0025.0025.0024.00
  Current Liabilities-34.8%5.007.005.006.0010.0010.008.007.007.007.006.005.007.007.005.009.007.008.008.007.006.00
Shareholder's Equity-36.5%8.0013.0018.0022.0027.0029.0041.0047.0046.0056.0059.0064.0055.0019.0019.0024.0016.0015.0015.0019.0021.00
  Retained Earnings-1.3%-393-388-383-379-374-368-355-349-343-332-329-323-317-312-308-300-295-290-287-281-276
  Additional Paid-In Capital0.0%401402401401401398397396390389387386372331327325312305303301297
Accumulated Depreciation-100.0%-2.00---3.00--------3.00--3.003.003.003.00
Shares Outstanding0%9.009.009.009.009.007.007.006.006.006.006.005.002.00--------
Float----12.00---13.00---110---122---38.00-
Cashflow (Last 12 Months)
(In Thousands)
Cashflow (Quarterly)
(In Thousands)
(*) denotes actual numbers (not divided by Thousands)
Description(%) Q/Q2024Q12023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q1
Cashflow From Operations-57.3%-5,900-3,750-4,472-6,691-4,085-5,007-4,640-5,472-7,976-5,088-3,786-2,612-4,736-3,731-3,963-2,948-4,975-5,616-4,480-4,626-5,535
  Share Based Compensation-123.0%-30.6813397.001903397104764929956867017941,579403417579452524454617691
Cashflow From Investing172.1%2,382-3,30310,6673,124519-10,8854,900-2,48616,752-9743,006-17,029-15,124-5.172,7827,096-1,9482,3005,2784,355-5,996
Cashflow From Financing-100.0%-30.0078.00-6,2212,474447-64.02--1*-8.3214,32040,4572,561-3,13212,7605,7951,6691,7112,7091,755
Get Full Access to Grufity – and Unlimited Downloads
Gain full access to fair value, watchlists, stock screener, unlimited page visits, and additional features by joining as a member today for just $1.99.
Try For Just $1.99

CLSN Income Statement

2024-03-31
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Operating expenses:  
Research and development$ 3,293,861$ 2,619,805
General and administrative1,717,5853,064,645
Total operating expenses5,011,4465,684,450
Loss from operations(5,011,446)(5,684,450)
Other income (expense):  
Investment income, net81,921253,070
Interest expense on loan facility(159,985)
Total other income (expense), net81,92193,085
Net loss$ (4,929,525)$ (5,591,365)
Weighted average shares outstanding - Basic9,399,8318,281,483
Weighted average shares outstanding - Diluted9,399,8318,281,483
Net loss per common share  
Net loss per common share - Basic$ (0.52)$ (0.68)
Net loss per common share - Diluted$ (0.52)$ (0.68)

CLSN Balance Sheet

2024-03-31
Condensed Consolidated Balance Sheets - USD ($)
Mar. 31, 2024
Dec. 31, 2023
Current assets:  
Cash and cash equivalents$ 2,346,978$ 5,838,566
Investment in debt securities - available for sale, at fair value7,461,8759,857,087
Advances and deposits on clinical programs and other current assets2,285,4902,545,051
Total current assets12,094,34318,240,704
Property and equipment (at cost, less accumulated depreciation and amortization)693,360751,906
Other assets:  
Deferred income tax asset1,280,385
Operating lease right-of-use assets, net1,487,0651,595,074
Deposits and other assets50,00050,000
Total other assets1,537,0652,925,459
Total assets14,324,76821,918,069
Current liabilities:  
Accounts payable – trade2,357,7763,515,192
Other accrued liabilities1,958,5753,390,521
Operating lease liability - current portion500,625485,421
Total current liabilities4,816,9767,391,134
Operating lease liability - non-current portion1,008,0491,139,293
Total liabilities5,825,0258,530,427
Commitments and contingencies
Stockholders’ equity:  
Preferred stock - $0.01 par value (100,000 shares authorized, and no shares issued or outstanding at March 31, 2024 and December 31, 2023)
Common stock - $0.01 par value (112,500,000 shares authorized; 9,400,911 and 9,399,811 shares issued at March 31, 2024 and December 31, 2023, respectively; and 9,400,889 and 9,399,789 shares outstanding at March 31, 2024 and December 31, 2023, respectively)94,00993,998
Additional paid-in capital401,470,148401,500,838
Accumulated other comprehensive loss133,10160,796
Accumulated deficit(393,112,327)(388,182,802)
Total stockholders’ equity before treasury stock8,584,93113,472,830
Treasury stock, at cost (22 shares at March 31, 2024 and December 31, 2023)(85,188)(85,188)
Total stockholders’ equity8,499,74313,387,642
Total liabilities and stockholders’ equity$ 14,324,768$ 21,918,069
CLSN
0
 WEBSITEhttps://celsion.com

Celsion Corp Frequently Asked Questions


What is the ticker symbol for Celsion Corp? What does CLSN stand for in stocks?

CLSN is the stock ticker symbol of Celsion Corp. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Celsion Corp (CLSN)?

As of Fri May 17 2024, market cap of Celsion Corp is 13.26 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of CLSN stock?

You can check CLSN's fair value in chart for subscribers.

What is the fair value of CLSN stock?

You can check CLSN's fair value in chart for subscribers. The fair value of Celsion Corp is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Celsion Corp is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for CLSN so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Celsion Corp a good stock to buy?

The fair value guage provides a quick view whether CLSN is over valued or under valued. Whether Celsion Corp is cheap or expensive depends on the assumptions which impact Celsion Corp's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for CLSN.

What is Celsion Corp's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Fri May 17 2024, CLSN's PE ratio (Price to Earnings) is -0.7 and Price to Sales (PS) ratio is 27.83. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. CLSN PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on Celsion Corp's stock?

In the past 10 years, Celsion Corp has provided -0.458 (multiply by 100 for percentage) rate of return.